VIVOS THERAPEUTICS, INC. (VVOS) Net margin 2019–2025
VIVOS THERAPEUTICS, INC. (VVOS) net profit margin by fiscal year — reported net income divided by reported revenue.
-121.4%FY2025 · since FY2019: -94.4% → -121.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -121.4% | -47.3 pp |
| FY2024 | -74.1% | +24.3 pp |
| FY2023 | -98.4% | +50.4 pp |
| FY2022 | -148.8% | -28.7 pp |
| FY2021 | -120.2% | -27.9 pp |
| FY2020 | -92.3% | +2.1 pp |
| FY2019 | -94.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VVOS financial trends
VVOS RevenueVVOS Net incomeVVOS Gross profitVVOS Gross marginVVOS Operating incomeVVOS Operating marginVVOS Operating cash flowVVOS Free cash flowVVOS Capital expendituresVVOS Return on equityVVOS Stock buybacksVVOS Dividends paidVVOS Total assetsVVOS Total liabilitiesVVOS Shareholders’ equityVVOS overview →